FA
PBH icon

Friess Associates’s Prestige Consumer Healthcare PBH Stock Holding History

Friess Associates’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-91,468
Closed -$4.58M – 119
2017
Q3 		$4.58M Sell
91,468
-198,532
-68% -$10.1M 0.4% 72
2017
Q2 		$15.3M Buy
+290,000
New +$15.5M 1.39% 31
2017
Q1 		– Sell
-230,000
Closed -$12M – 151
2016
Q4 		$12M Buy
+230,000
New +$11.1M 1.18% 48

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MRCP
Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Friess Associates's PBH Position: Q4 2017 in Review

Friess Associates sold out of Prestige Consumer Healthcare (PBH) in Q4 2017, closing a stake of 91,468 shares — an estimated $4.58M sold.

Friess Associates first reported a position in PBH in Q4 2016 and held it in 3 quarters. The position peaked at $15.3M in Q2 2017. 251 funds tracked by Wall St. Rank hold PBH as of Q4 2017.

  • Friess Associates reported no remaining Prestige Consumer Healthcare position as of Q4 2017 after selling out during the quarter.
  • Friess Associates sold 91,468 Prestige Consumer Healthcare shares in Q4 2017, an estimated $4.58M.
  • Friess Associates first reported a position in Prestige Consumer Healthcare in Q4 2016 and held it in 3 quarters.
  • Friess Associates's Prestige Consumer Healthcare position peaked at $15.3M in Q2 2017.
  • 251 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2017.

Based on Friess Associates's 13F filing for Q4 2017, filed 14 Feb 2018.